Key result
Treatment with placitaxel completely diminished the cutaneous angiosarcoma lesion in an old man, though he subsequently developed pulmonary fibrosis and died 6 months after diagnosis.
Case Report (n=1)
Early detection and treatment with paclitaxel can lead to complete remission of cutaneous angiosarcoma lesions, though fatal complications like pulmonary fibrosis may occur.
No takes yet. Share an insight, caveat, or question.
Paclitaxel may clear cutaneous angiosarcoma lesions but risks fatal pulmonary fibrosis; leaves open net benefit pending controlled data.
Pestoni et al. (2005) conducted a case report in Cutaneous angiosarcoma of the face and scalp (n=1). Placitaxel was evaluated on Lesion response and survival. Treatment with placitaxel completely diminished the cutaneous angiosarcoma lesion in an old man, though he subsequently developed pulmonary fibrosis and died 6 months after diagnosis.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: